Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

Transgenic Organisms

Transgenic Organisms

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A novel replicase-mediated self-amplifying RNA amplification mechanism of the SARS-CoV-2 replication-transcription system.

Biochemical and biophysical research communications·2025

Same author

MiR-302-Mediated Somatic Cell Reprogramming and Method for Generating Tumor-Free iPS Cells Using miR-302.

Methods in molecular biology (Clifton, N.J.)·2020

Same author

The microRNA and the perspectives of miR-302.

Heliyon·2019

Same author

The MicroRNA.

Methods in molecular biology (Clifton, N.J.)·2018

Same author

Gene Silencing In Vitro and In Vivo Using Intronic MicroRNAs.

Methods in molecular biology (Clifton, N.J.)·2018

Same author

Isolation and Identification of Gene-Specific MicroRNAs.

Methods in molecular biology (Clifton, N.J.)·2018

Search research articles

Related Experiment Video

Updated: May 18, 2026

Loss-of-Function Approach in the Embryonic Chick Retina by Using Tol2 Transposon-Mediated Transgenic Expression of Artificial microRNAs

Loss-of-Function Approach in the Embryonic Chick Retina by Using Tol2 Transposon-Mediated Transgenic Expression of Artificial microRNAs

Published on: May 18, 2022

Transgene-like animal models using intronic microRNAs.

Shi-Lung Lin¹, Shin-Ju E Chang, Shao-Yao Ying

¹Division of Regenerative Medicine, WJWU and LYNN Institute for Stem Cell Research, Santa Fe Springs, CA, USA. shilungl@mirps.org

Methods in Molecular Biology (Clifton, N.J.)

|September 26, 2012

Summary

Researchers developed a new transgenic animal model strategy using intronic microRNAs (miRNAs) for gene silencing. This breakthrough enables in vivo miRNA research and drug evaluation, advancing disease pathology studies.

More Related Videos

Generation of Genetically Modified Mice through the Microinjection of Oocytes

Generation of Genetically Modified Mice through the Microinjection of Oocytes

Published on: June 15, 2017

In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression

In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression

Published on: March 29, 2019

Related Experiment Videos

Last Updated: May 18, 2026

Loss-of-Function Approach in the Embryonic Chick Retina by Using Tol2 Transposon-Mediated Transgenic Expression of Artificial microRNAs

Loss-of-Function Approach in the Embryonic Chick Retina by Using Tol2 Transposon-Mediated Transgenic Expression of Artificial microRNAs

Published on: May 18, 2022

Generation of Genetically Modified Mice through the Microinjection of Oocytes

Generation of Genetically Modified Mice through the Microinjection of Oocytes

Published on: June 15, 2017

In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression

In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression

Published on: March 29, 2019

Area of Science:

Molecular Biology
Genetics
Developmental Biology

Background:

Transgenic animal models are crucial for in vivo gene function and drug mechanism studies, serving as vital tools for disease research.
MicroRNAs (miRNAs) are regulatory RNAs involved in gene silencing, with potential therapeutic applications against cancer and viral mutations.
Existing research lacked a dedicated transgenic animal model for microRNA studies, hindering in vivo investigations.

Purpose of the Study:

To develop a novel transgenic strategy for in vivo microRNA (miRNA) research and gene silencing.
To create functional transgenic animal models for studying miRNA-associated target gene functions.
To establish a platform for the in vivo evaluation of miRNA-related drug mechanisms.

Main Methods:

Developed a transgenic strategy utilizing intronic microRNAs (miRNAs) for gene silencing in zebrafish, chicken, and mouse.
Inserted hairpin-like pre-miRNA structures into the intron regions of genes, enabling co-expression and processing by natural cellular machinery.
Employed retroviral transfection systems for tissue-specific gene expression and selected stable transgenic lines for research.

Main Results:

Successfully generated transgenic animal models expressing intronic miRNAs.
Demonstrated that mature miRNAs were transcribed, co-expressed with the encoding gene, and processed via natural RNA splicing.
Validated the utility of the intronic miRNA-expressing system for both miRNA research and in vivo target gene function evaluation.

Conclusions:

The developed intronic miRNA-expressing system provides the first functional transgenic animal models for miRNA research.
This novel approach facilitates in vivo studies of miRNA functions and their roles in disease pathology.
The transgenic models are valuable for evaluating miRNA-associated target gene functions and potential therapeutic strategies.